Start-ups partner on plan to distribute rapid coronavirus tests to the house

The business behind one of the new completely at-home COVID-19 tests is partnering with a digital health platform to deliver rapid diagnostics to customers.

Gauss is working to produce a million tests over the next month, with plans to scale up to 30 million tests in the first quarter of 2021.

Flashback: The FDA last week authorized the very first fast, at-home coronavirus test– manufactured by Ellume and offered across the counter without a prescription.

https://covid19globalcases.com/start-ups-partner-on-plan-to-distribute-rapid-coronavirus-tests-to-the-house/